Prognostic value of systemic immune-inflammation index in patients with gastric cancer treated with immune checkpoint inhibitors

doi:10.3748/wjg.v32.i34.119567

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 34

This Article

(5)

(4)

(0)

(13)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Sep 14, 2026; 32(34): 119567
Published online Sep 14, 2026. doi: 10.3748/wjg.v32.i34.119567

Table 3 Multivariate logistic regression analysis of the risk factors for progressive disease within six months in gastric cancer patients receiving immune checkpoint inhibitors

Parameters	Coefficient	SE	Wald Stat	P value	OR	OR 95%CI lower	OR 95%CI upper
Eastern Cooperative Oncology Group (2)	0.554	0.237	2.337	0.019	1.740	1.094	2.770
Clinical staging (IV)	0.900	0.400	2.247	0.025	2.459	1.122	5.391
Number of distant metastases (≥ 2)	0.684	0.342	1.999	0.046	1.982	1.014	3.875
Treatment regimen (combination therapy)	-0.721	0.342	-2.108	0.035	0.486	0.249	0.951
Programmed cell death ligand 1 overexpression (combined positive score ≥ 1)	0.804	0.367	2.192	0.028	2.234	1.089	4.586
Systemic immune-inflammation index	0.006	0.001	5.566	< 0.001	1.006	1.004	1.009

OR: Odds ratio.

Full Size Table

Citation: Guo R, Gao M. Prognostic value of systemic immune-inflammation index in patients with gastric cancer treated with immune checkpoint inhibitors. World J Gastroenterol 2026; 32(34): 119567
URL: https://www.wjgnet.com/1007-9327/full/v32/i34/119567.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i34.119567

Guo R, Gao M. Prognostic value of systemic immune-inflammation index in patients with gastric cancer treated with immune checkpoint inhibitors. World J Gastroenterol 2026; 32(34): 119567 [DOI: 10.3748/wjg.v32.i34.119567]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.